基因沉默
CTGF公司
肝星状细胞
下调和上调
癌症研究
肝纤维化
化学
纤维化
遗传增强
小干扰RNA
转染
基因传递
细胞培养
治疗效果
肝癌
肝纤维化
RNA干扰
细胞
医学
基因表达
细胞生物学
信使核糖核酸
阿霉素
病态的
纳米囊
细胞生长
靶向治疗
作者
Yanyan Jiang,Xinliu Duan,Zitong Qi,Xuan Zhou,Wenjing Song,Li Jiang,Yawen Yu,Yueli Liu,Xu Chai,Xiaohu Tang,Xiaoyan He,Hangyu Xia,Qun Liu,Peng Zhang,Aiping Wang
标识
DOI:10.1186/s12951-026-04430-1
摘要
Liver fibrosis constitutes a progressive pathological condition for which TGF-β1 pathway-targeted siRNA therapy holds considerable therapeutic potential. Nevertheless, clinical application of TGF-β1 siRNA is critically limited by inherent instability and inefficient delivery in vivo. In this study, we engineered an innovative siRNA delivery platform through the integration of turmeric-derived exosome-like nanovesicles (TDEs) with a metal-organic framework (ZIF-8) to generate TDEs@ZIF-8@TGFβ1siRNA nanoparticles, thereby enhancing siRNA delivery efficiency and therapeutic efficacy in liver fibrosis. Characterization revealed TDEs@ZIF-8@TGFβ1siRNA nanoparticles exhibited a well-defined nanostructure with a high TGF-β1 siRNA encapsulation efficiency of 64.73%. Additionally, the system exhibited pH-responsive release and lysosomal escape capabilities, significantly enhancing siRNA stability and cellular uptake efficiency. In vitro, TDEs@ZIF-8@TGFβ1siRNA effectively inhibited hepatic stellate cells (HSCs) activation, reducing TGF-β1, Collagen I, and CTGF mRNA levels by 78.6%, 72.1%, and 69.4%, respectively. In a CCl 4 -induced mouse model of liver fibrosis, TDEs@ZIF-8@TGFβ1siRNA treatment significantly improved hepatic function, reducing serum ALT and AST levels by 59.8% and 62.7%, respectively. Histological staining revealed a 71% reduction in fibrotic area, concomitant with marked downregulation of α-SMA and Collagen I expression by approximately 68% and 74%. Mechanistically, the therapeutic effects were mediated through TGF-β1 gene silencing and consequent inhibition of the TGF-β/Smad pathway, resulting in attenuated HSCs activation and diminished collagen deposition. These findings indicate that TDEs@ZIF-8@TGFβ1siRNA represents a promising biomimetic strategy for targeted gene therapy in liver fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI